Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Zepbound price, strengths & recalls

Brand of tirzepatide (generic)

Pharmacies pay $482.79 for 2.4 mL of Zepbound 12.5 mg/mL, 2.4 mL pen this week, and from $482.79 to $1,052.46 across its 12 priced strengths and forms. It has 28 recalls on record, none ongoing. Its official label last changed on September 2, 2026.

Brand
Pharmacies pay$482.79for 2.4 mL of 12.5 mg/mL, 2.4 mL pen+0.1% in 4 weeks
Fair cash price
$565.71
Strengths
12
Makers
1
Updated
Nov 11

Zepbound price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
5 mg/mL, 0.5 mL auto-injector Brand$526.23$1,052.46 / 2 mLNo changeNo change
10 mg/mL, 0.5 mL auto-injector Brand$526.10$1,052.19 / 2 mLNo changeNo change
15 mg/mL, 0.5 mL auto-injector Brand$526.04$1,052.08 / 2 mLNo changeNo change
20 mg/mL, 0.5 mL auto-injector Brand$526.07$1,052.14 / 2 mLNo changeNo change
25 mg/mL, 0.5 mL auto-injector Brand$525.83$1,051.67 / 2 mLNo change-0.1%
30 mg/mL, 0.5 mL auto-injector Brand$525.93$1,051.86 / 2 mLNo changeNo change
4.17 mg/mL, 2.4 mL pen Brand$201.39$483.33 / 2.4 mL+0.1%
8.33 mg/mL, 2.4 mL pen Brand$201.20$482.88 / 2.4 mL+0.1%
12.5 mg/mL, 2.4 mL pen Brand$201.16$482.79 / 2.4 mL+0.1%
16.7 mg/mL, 2.4 mL pen Brand$281.78$676.28 / 2.4 mL+0.1%
20.8 mg/mL, 2.4 mL pen Brand$282.23$677.36 / 2.4 mL+0.1%
25 mg/mL, 2.4 mL pen Brand$281.68$676.02 / 2.4 mL+0.1%

Zepbound vs generic tirzepatide

There is no generic version of Zepbound on the market yet. Its last listed patent or exclusivity runs to July 22, 2039 - generics often follow, though court cases and settlements can move the date either way.

GenericTirzepatide prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
12 ongoing recalls28 recalls on record

Recalls

Showing the 6 most relevant of 28 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for zepbound? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedSeptember 2, 2026
Version40 of 22
EffectiveAug 28, 2026
Read the label

These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND.ZEPBOUND® (tirzepatide) Injection, for subcutaneous useInitial U.S. Approval: 2022

This drug has a boxed warning

WARNING: RISK OF THYROID C-CELL TUMORS

In rats, tirzepatide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether ZEPBOUND causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined

[see Warnings and Precautions (5.1) and Nonclinical Toxicology (13.1)].

ZEPBOUND is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

[see Contraindications (4)]. Counsel patients regarding the potential risk for MTC with the use of ZEPBOUND and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness). Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with ZEPBOUND

[see Contraindications (4) and Warnings and Precautions (5.1)].

WARNING: RISK OF THYROID C-CELL TUMORS

See full prescribing information for complete boxed warning.

In rats, tirzepatide causes thyroid C-cell tumors. It is unknown whether ZEPBOUND causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined (5.1, 13.1).

ZEPBOUND is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors (4, 5.1).

Recent major changes (as listed on the label)

Dosage and Administration (2.4)

| 01/2026

|

Warnings and Precautions

| |

Severe Gastrointestinal Adverse Reactions (5.2)

| 02/2026

|

Diabetic Retinopathy Complications in Patients with Type 2 Diabetes Mellitus (5.8)

| 08/2026

|

Suicidal Behavior and Ideation (Removed) | 02/2026

|

Never Share a ZEPBOUND KwikPen Between Patients (5.10)

| 01/2026

|

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA217806 · Eli Lilly And Co
First approved
November 8, 2023 (3 years ago)
Latest approved change
August 26, 2026
Approved label
PDF, Sep 10, 2026
Generic makers
None on the market
Last patent listed
July 22, 2039
Exclusivity ends
December 20, 2027

Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.

Zepbound questions

How much does zepbound cost without insurance?

Pharmacies pay about $482.79 for 2.4 mL of zepbound 12.5 mg/mL, 2.4 mL pen ($201.16 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $565.71. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Zepbound?

Yes: tirzepatide. Compare tirzepatide prices.

Is zepbound in shortage?

No shortage is reported for zepbound right now. We check the national shortage list every day.

Has zepbound been recalled?

28 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the zepbound label last change?

The official label was last updated on September 2, 2026 (version 40). See what changed.

Talk about zepbound

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.